πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,720 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9707289

Biochemically stabilized HIV-1 ENV trimer vaccine

NATIONAL INSTITUTES OF HEALTH (NIH), THE UNITED STATES OF AMERICA DEPT. OF HEALTH AND HUMAN SERVICES (DHHS). Β· Granted Tue Jul 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9707287

Attenuated mutant dengue viruses comprising a mutation in the NS4B non-structural protein

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jul 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9707283

Genetically modified babesia parasites expressing protective tick antigens and uses thereo

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Jul 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9707230

Activators of human pyruvate kinase

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jul 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9701740

Cell-penetrating anti-DNA antibodies and uses thereof inhibit DNA repair

THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS Β· Granted Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9701718

Adenovirus serotype 26 and serotype 35 filovirus vaccines

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFERβ€”NATIONAL INSTITUTES OF HEALTH Β· Granted Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9701611

Salts of treprostinil

United Therapeutics Corporation Β· Granted Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9700578

Use of nitrite salts for the treatment of cardiovascular conditions

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9700562

Triazine compounds and compositions thereof and methods for treating malaria and chemoprop

The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research Β· Granted Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9695230

Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envel

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jul 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9694062

Plasmodium falciparum sporozoite and liver stage antigens

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Jul 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9688739

T cell receptors and related materials and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9687542

Rift valley fever virus replicon particles and use thereof

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services Β· Granted Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9687461

Method for detecting risk factor for metabolic syndrome or hyperferritinemia

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9683269

Infectious hepatitis C viruses of genotype 3A and 4A and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9683263

Detection and treatment of irritable bowel syndrome

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9683024

Recombinantly expressed plasmodium CelTOS antigen and methods of use thereof

The United States of America as represented by the Secretary of the Army Β· Granted Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9682116

Date pit composition for the treatment of animals

UNITED ARAB EMIRATES UNIVERSITY Β· Granted Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9682107

Postnatal stem cells and uses thereof

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9682088

Method for treating uterine fibroids

The United States of America as Represented by the Secretary, Dept. of Health and Human Services Β· Granted Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9676858

Human bispecific EGFRvIII antibody and CD3 engaging molecules

The United States of America as Represented by the Secretary Department of Health and Human Services (NIH) Β· Granted Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9676857

Soluble engineered monomeric Fc

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9676846

Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9676788

Aza-epoxy-guaiane derivatives and treatment of cancer

The United States of America, as represented by the Secretary, Health and Human Services Β· Granted Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted